|
Title
|
|
|
|
Flow cytometric analysis of phospho-p38 mitogen-activated kinase (MAPK): p38 MAPK does not mediate the effect of adalimumab on peripheral T cell cytokine production in rheumatoid arthritis
| |
|
Author
|
|
|
|
| |
|
Abstract
|
|
|
|
| Background: The therapeutic effect of TNFá inhibition in rheumatoid arthritis (RA) is accompanied by an altered peripheral T cell cytokine profile, but the underlying mechanisms are not well known. In CD4+ T cells, TNF signalling includes the p38 MAP kinase (MAPK) pathway, which is also involved in proliferation and production of IL-4 and IFNã. Methods: Phosphorylation of p38 MAPK was analysed flow cytometrically in peripheral blood mononuclear cells (PBMC) from healthy individuals and RA patients before and after adalimumab therapy. Cytokine production by CD3/CD28-stimulated PBMC was measured in the supernatant. Results: Despite a transient activation of p38 MAPK in response to cellular stress from the cell separation, a significant decrease of spontaneous p38 MAPK phosphorylation was observed after adalimumab, compared to RA patients with active disease. Brief stimulation with TNFá/IL-1â significantly activated p38 MAPK after but not before adalimumab therapy. In CD3/CD28-stimulated PBMC, significantly less p38 MAPK activation and increased IFNã production were observed after adalimumab therapy. Conclusion: In rheumatoid arthritis, adalimumab therapy decreases the phosphorylation of p38 MAPK except for its response to TNF/IL-1, while enhancing the production of IFNã. This suggests that p38 MAPK is not directly involved in the effect of TNF inhibition on cytokine production. |
| |
|
Language
|
|
|
|
English
| |
|
Source (journal)
|
|
|
|
Cytokine. - Philadelphia, Pa
| |
|
Publication
|
|
|
|
Philadelphia, Pa
:
2009
| |
|
ISSN
|
|
|
|
1043-4666
| |
|
DOI
|
|
|
|
10.1016/J.CYTO.2009.06.008
| |
|
Volume/pages
|
|
|
|
47
:3
(2009)
, p. 178-184
| |
|
ISI
|
|
|
|
000269784300006
| |
|
Full text (Publisher's DOI)
|
|
|
|
| |
|